Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00847288 · ClinicalTrials.gov registry record · Phase 4
OptiVol® Care Pathway
A Phase 4 study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,682
- Enrollment target
NCT00847288 is a Phase 4 study that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 1,682 participants.
The verdict
NCT00847288, a Phase 4 study, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,682 participants
- Enrollment target
Study Summary
Medtronic, Inc. is sponsoring the OptiVol® Care Pathway Study, a prospective, randomized, multi-center, post-market clinical trial in the United States. The purpose of this clinical trial is to compare monthly versus quarterly review of Cardiac Compass® Trends with OptiVol for initiation of clinical action. It is hypothesized that monthly review of Cardiac Compass Trends with OptiVol will shorten time to clinical action as compared to quarterly review.
Interventions
- OTHER Monthly Review Arm
- OTHER Quarterly Review Arm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,682 participants |
| Start Date | 2009-03 |
| Est. Completion | 2011-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00847288
The ClinicalTrials.gov registry entry for NCT00847288 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 1,682 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Monthly Review Arm is the first listed.
NCT00847288 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00847288 about?
NCT00847288 is a clinical study titled "OptiVol® Care Pathway". Medtronic, Inc. is sponsoring the OptiVol® Care Pathway Study, a prospective, randomized, multi-center, post-market clinical trial in the United States. The purpose of this clinical trial is to compare monthly versus quarterly review of Cardiac Compass® Trends with OptiVol for initiation of clinical...
What is the current status of trial NCT00847288?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,682 participants. The study started on 2009-03. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00847288?
The interventions under investigation include: Monthly Review Arm (OTHER), Quarterly Review Arm (OTHER).
Who is sponsoring clinical trial NCT00847288?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.